Navigation Links
Harnessing microbes, one by one, to build a better nanoworld

Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the introduction of the Applied Biosystems Advanced Gene Expression Service Provider Program, a new program for service providers who are interested in accessing Applied Biosystems comprehensive solution for gene expression analysis, including the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan® Gene Expression Assays for target validation. The program includes a bundled product option for the entire gene expression workflow application and technical and promotional support that is expected to enhance service providers?business offerings.

The program, intended to assist service providers in genetic analysis using interpretation tools and content to advance scientific research while helping them achieve necessary return on investment, was announced today in advance of this weekend’s annual World Microarray Congress in Vancouver, Canada.

The Applied Biosystems Expression Array System forms the technical platform for the program and can be optionally bundled with companion products that comprise Applied Biosystems?whole solution for gene expression analysis, including microarrays for human, mouse, and rat, TaqMan® Gene Expression Assays, and Real-Time PCR Systems.

Additional data analysis and promotional support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program. Participants will have access to the Celera Discovery System?Online Platform and Panther?Protein Classification System, a Service Provider web link on the Applied Biosystems Web site, and on-site seminars to educate customers to help provide increased business opportunities.

“Under the program, organizations offering gene expression analysis services can now offer their clients a complete gene expression analysis system backed with technical and promotional support package from the leader in gene expression technologies ,?said Catherine M. Burzik, President of Applied Biosystems.

The Applied Biosystems Expression Array System is a highly sensitive gene expression detection system. The system detects more genes and achieves more than a 10-fold increase in sensitivity while using less sample for the detection of genes expressed at very low levels compared with conventional fluorescent microarrays. The system uses a chemiluminescence-detection instrument, software, and chemistries to deliver unambiguous gene results that are highly sensitive and reproducible.

The PCR process and the 5' nuclease detection process are covered by patents owned by Roche Molecular System, Inc. and F. Hoffmann-La Roche Ltd ("Roche"). Performing services using these patented processes may require additional licenses from Applied Biosystems or Roche.

For more information, visit http://docs.appliedbiosystems.com/pebiodocs/00114098.pdf


'"/>

Source:


Related biology news :

1. Harnessing genomic research
2. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
3. Timing is everything: First step in protein building revealed
4. Signaling protein builds bigger, better bones in mice
5. Structure-building cell signals also may influence learning and memory
6. Carnegie Mellon scientists create PNA molecule with potential to build nanodevices
7. Scientist uses form to explain function of key building blocks of life
8. Mouse study: New muscle-building agent beats all previous ones
9. University of Utah to help build bionic arm
10. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure
11. Intensive statin therapy may partially reverse plaque build-up in arteries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):
(Date:8/21/2017)... ... August 21, 2017 , ... Boston Strategic Partners, Inc. (BSP), ... Economics and Outcomes Research (HEOR) and ‘big data’ to provide a variety of ... exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. BSP has access to ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... announce that they will feature Federal Hybrids, Inc. in an upcoming episode, scheduled ... , American Farmer will explore Federal Hybrids, the independent, family-owned seed company. ...
(Date:8/17/2017)... CA (PRWEB) , ... August 17, 2017 , ... ... for cancer research and personalized medicine, today announced the launch of a new ... City, Missouri. The study’s goal is to evaluate the potential for early detection ...
(Date:8/16/2017)... ... August 16, 2017 , ... Recent studies ... type. Many treatments for specific cancers, such as breast, prostate, or lung, target ... androgen deprivation therapy for advanced prostate cancer. , This therapy limits the ...
Breaking Biology Technology: